News

AddToAny

Google+ Facebook Twitter Twitter

“POCT benefits patients and cuts costs”

On-site pathology testing is allowing remote Australians to receive effective emergency medical treatment, while saving millions, according to researchers.

In a study funded by the Emergency Medicine Foundation Australasia, a research team assessed both the medical and cost benefits of using point-of-care testing (POCT) for acute medical care in six remote health clinics in the Northern Territory over a six-month period.

It is one of the first projects in the world to quantitatively evaluate the clinical and economic benefits of POCT in a remote setting, according to the team.

Project Coordinator Brooke Spaeth said: “Up to now, we had very little hard research data to support the cost benefits of using POCT, it was mostly anecdotal.

“We now have proof that the technology improved the clinical and operational outcomes for acutely ill patients in remote communities in the Northern Territory.”

It reduced the need for medical evacuations by up to 35% in the clinical conditions investigated, which led to “significant cost savings”.

The research team evaluated the use of POCT for 200 patients suffering from acute chest pain, acute diarrhoea or acute renal failure.

Image credit | Shutterstock 

Related Articles

The lesser horseshoe bat (Rhinolophus hipposideros)-Image Credit | istock-816193242

Bat swarming and immunity

Bats carry some of the deadliest zoonotic diseases that can infect both humans and animals, such as Ebola and COVID-19.

Pancreas or pancreatic cancer with organs and tumors or cancerous cells 3D rendering illustration with male bodyImage Credit | istock-1467893187

Fibroblast cells and pancreatic cancer growth

Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, it is claimed.

brain tumour CREDIT_science photo library

Pores for thought

A team from Nottingham looks at intraoperative molecular diagnosis of brain tumours using nanopore sequencing.

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Top